R Squared Ltd Purchases New Shares in Afya Limited $AFYA

R Squared Ltd purchased a new stake in Afya Limited (NASDAQ:AFYA) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 14,788 shares of the company’s stock, valued at approximately $264,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Doma Perpetual Capital Management LLC grew its stake in Afya by 4.4% in the 1st quarter. Doma Perpetual Capital Management LLC now owns 592,220 shares of the company’s stock valued at $10,619,000 after acquiring an additional 25,111 shares during the period. Perpetual Ltd boosted its stake in Afya by 1.8% during the 2nd quarter. Perpetual Ltd now owns 151,180 shares of the company’s stock worth $2,700,000 after purchasing an additional 2,730 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in Afya by 167.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock worth $809,000 after purchasing an additional 28,226 shares during the last quarter. Cerity Partners LLC acquired a new stake in Afya during the 1st quarter worth $476,000. Finally, Wealthedge Investment Advisors LLC acquired a new stake in Afya during the 1st quarter worth $230,000. Institutional investors and hedge funds own 88.02% of the company’s stock.

Wall Street Analyst Weigh In

AFYA has been the topic of several recent research reports. JPMorgan Chase & Co. raised shares of Afya from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $23.50 to $24.50 in a research note on Monday, September 8th. Wall Street Zen cut shares of Afya from a “strong-buy” rating to a “buy” rating in a research note on Saturday, October 18th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a research note on Friday. Morgan Stanley set a $17.50 price target on shares of Afya and gave the company an “overweight” rating in a research report on Wednesday, August 6th. Finally, Citigroup raised shares of Afya from a “sell” rating to a “neutral” rating and lowered their price target for the company from $16.00 to $14.00 in a research report on Tuesday, July 29th. Three analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Afya presently has a consensus rating of “Hold” and an average price target of $18.20.

Afya Trading Down 2.2%

Shares of AFYA stock opened at $14.71 on Friday. The company’s 50-day moving average price is $15.27 and its 200-day moving average price is $16.56. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.22. The stock has a market cap of $1.38 billion, a price-to-earnings ratio of 11.14, a PEG ratio of 0.44 and a beta of 0.61. Afya Limited has a twelve month low of $13.47 and a twelve month high of $19.90.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.